/
Gene Ther
Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study
- J. Westermann
- A. Floercken
- G. Willimsky
- A. van Lessen
- J. Kopp
- A. Takvorian
- K. Joehrens
- A. Lukowsky
- C. Schoenemann
- B. Sawitzki
- H. Pohla
- R. Frank
- B. Doerken
- D.J. Schendel
- T. Blankenstein
- A. Pezzutto